Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Halozyme Therapeutics nets $38.2 million by selling 6.15 million new shares at $6.50 per share
Halozyme Therapeutics nets $38.2 million by selling 6.15 million new shares at $6.50 per share
Halozyme Therapeutics nets $38.2 million by selling 6.15 million new shares at $6.50 per share
Submitted by
admin
on June 23, 2009 - 10:20am
Source:
Yahoo/AP
News Tags:
Halozyme
Headline:
Halozyme Therapeutics nets $38.2 million by selling 6.15 million new shares at $6.50 per share
Do Not Allow Advertisers to Use My Personal information
